Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 255 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2926 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
13 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-11-06 | 2021-01-28 | 128025 |
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-02-18 | 2021-05-13 | 134343 |
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-04-08 | 2021-05-13 | 137185 |
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-05-12 | 2022-12-15 | 160454 |
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-04-27 | 2025-05-21 | 190785 |
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-16 | 2023-10-06 | 195078 |
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-20 | 2023-07-05 | 195827 |
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-03 | 2025-05-21 | 209148 |
| TEVA-TECNAL | 330MG 50MG 40MG | TABLET | Resolved | 2019-06-13 | 2019-07-15 | 86620 |
| TEVA-TECNAL | 330MG 50MG 40MG | CAPSULE | Resolved | 2019-08-29 | 2020-07-10 | 92657 |
| TEVA-TECNAL | 50MG 40MG 330MG | TABLET | Resolved | 2020-07-23 | 2020-09-24 | 120896 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Resolved | 2022-02-10 | 2022-07-01 | 154714 |
| TEVA-TECNAL | 330MG 40MG 50MG | TABLET | Resolved | 2022-04-21 | 2024-01-19 | 159189 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Resolved | 2022-07-25 | 2022-10-18 | 165459 |
| TEVA-TECNAL | 330MG 40MG 50MG | TABLET | Resolved | 2023-06-20 | 2023-07-06 | 195850 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Resolved | 2024-04-05 | 2024-06-13 | 224448 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Actual shortage | 2024-09-05 | 2025-10-17 | 236799 |
| TEVA-TECNAL C 1/2 | 330MG 50MG 30MG 40MG | CAPSULE | Resolved | 2019-10-31 | 2020-02-07 | 97608 |
| TEVA-TECNAL C 1/2 | 330MG 50MG 30MG 40MG | CAPSULE | Resolved | 2020-03-06 | 2020-03-26 | 107973 |
| TEVA-TECNAL C 1/2 | 50MG 40MG 330MG 30MG | CAPSULE | Resolved | 2021-03-25 | 2021-04-15 | 136310 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-GLYBURIDE | 2.5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258547 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258383 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN | 150MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260527 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260546 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 150MG 12.5MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260549 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |